American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6410)
  2. Solid Tumor Oncology Division (5548)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1769)
  5. Surgery (1639)
  6. Epidemiology and Biostatistics (1496)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1380)
  9. Gastrointestinal Oncology Service (1357)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2587)
  3. Editorial (78)
  4. Review (69)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6410)
  2. Solid Tumor Oncology Division (5548)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1769)
  5. Surgery (1639)
  6. Epidemiology and Biostatistics (1496)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (308)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (297)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8709)
  2. JCO Precision Oncology (172)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (12)

More Publications

Results (9189)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer
    Journal Article

    Burtness, B.; Flamand, Y.; Quon, H.; Weinstein, G. S.; Mehra, R.; Garcia, J. J.; Kim, S.; O'Malley, B. W.; Ozer, E.; Ikpeazu, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
    Journal Article

    Avet-Loiseau, H.; Davies, F. E.; Samur, M. K.; Corre, J.; D'Agostino, M.; Kaiser, M. F.; Raab, M. S.; Weinhold, N.; Gutierrez, N. C.; Paiva, S. B.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Optimal management of stage II seminoma: Preventing harm while preserving cure
    Review

    Conduit, C.; Bagrodia, A.; Hamilton, R. J.; Feldman, D. R.; Tran, B.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Call to action for treatment of food insecurity: A vital element of equitable cancer care
    Editorial

    Gany, F. M.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Barriers to immune checkpoint inhibitor access for patients with cancer in southeast Asia: Challenges and policy implications
    Editorial

    Go, A. E.; Ho, F. D. V.; Feliciano, E. J. G.; Iyengar, P.; Chitapanarux, I.; Charoentum, C.; Bhoo-Pathy, N.; Satar, N. F. A.; Ting, F. I. L.; Dee, E. C.
    JCO Global Oncology (2025)

    Fulltext@MSK | Save
  • Sociodemographic features, health care costs, and treatment implications of genomic classifier testing for localized prostate cancer in the United States
    Journal Article

    Janopaul-Naylor, J. R.; Patil, D.; Joshi, S.; Sanda, M. G.; Sebastian, N.; Salari, K.; Dodge, J.; Dhere, V. R.; Hershatter, B. W.; Patel, P. R.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • SUPRAME: A phase 3 trial comparing IMA203, an engineered T-cell receptor expressing T cell therapy (TCR-T) vs investigator's choice in patients with previously treated advanced cutaneous melanoma
    Meeting Abstract

    Luke, J. J.; Warner, A. B.; Chmielowski, B.; Diab, A.; Gebhardt, C.; Hernandez-Aya, L. F.; Hu-Lieskovan, S.; Karapetyan, L.; Lawrence, D. P.; McKean, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase I study of AFNT-211, autologous CD4(+) and CD8(+) T cells engineered to express a high avidity HLA-A(*)11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors
    Meeting Abstract

    Basu, S. K.; Khan, B.; Payumo, F.; Wan, R.; Chiorean, E. G.; Gahvari, Z.; Hecht, J. R.; Hurwitz, M. E.; Leidner, R. S.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save